Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Payables (2016 - 2025)

Icu Medical's Payables history spans 17 years, with the latest figure at $154.4 million for Q4 2025.

  • For the quarter ending Q4 2025, Payables rose 4.29% year-over-year to $154.4 million, compared with a TTM value of $154.4 million through Dec 2025, up 4.29%, and an annual FY2025 reading of $154.4 million, up 4.29% over the prior year.
  • Payables for Q4 2025 was $154.4 million at Icu Medical, down from $171.8 million in the prior quarter.
  • The five-year high for Payables was $215.9 million in Q4 2022, with the low at $62.0 million in Q3 2021.
  • Average Payables over 5 years is $153.1 million, with a median of $161.3 million recorded in 2023.
  • Year-over-year, Payables crashed 31.0% in 2021 and then skyrocketed 230.67% in 2022.
  • Tracing ICUI's Payables over 5 years: stood at $81.1 million in 2021, then surged by 166.13% to $215.9 million in 2022, then plummeted by 30.51% to $150.0 million in 2023, then dropped by 1.34% to $148.0 million in 2024, then grew by 4.29% to $154.4 million in 2025.
  • Per Business Quant, the three most recent readings for ICUI's Payables are $154.4 million (Q4 2025), $171.8 million (Q3 2025), and $168.8 million (Q2 2025).